TY - JOUR AU - Park, Kang-Seo AU - Lee, Dae Ho PY - 2018 TI - The importance of galectin-3 as a novel target for lung cancer patients harboring KRAS mutation JF - Translational Cancer Research; Vol 7, Supplement 1 (February 06, 2018): Translational Cancer Research Y2 - 2018 KW - N2 - Precision cancer medicine using molecular targeted therapies is a cornerstone for cancer therapy during the last two decades. However, the drug resistance regardless of primary or acquired one is still a big hurdle which should be overcome to improve cancer therapy and its outcomes. In this regard, lung cancer is a prototype. UR - https://tcr.amegroups.org/article/view/18412